Research & Development

Biocellvia’s pipeline

Focused on the needs of the industry, Biocellvia is constantly broadening its skills and looking ahead. Innovation is at the root of our project, as a researcher and company-founder, it’s also my philosophy.

Yvon Julé

Pathology

Research & Development

Validation

Commercial

Idiopathic Pulmonary Fibrosis (IPF) 100%
Chronic Obstructive Pulmonary Disease (COPD) 100%
Small Airway Remodelling (SAR) 100%
Asthma 80%
Non Alcoholic SteatoHepatitis (NASH) 80%
Lung Cancer 50%
Breast Cancer 30%
CNS & NeuroDegenerative diseases 30%

2016

2017

2017

Q2 2018

Q2 2018

Q4 2018

Q4 2018

Q1 2019